Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells (2024)

  • Article
  • Published:

Nature Nanotechnology volume17,pages 98–106 (2022)Cite this article

  • 53k Accesses

  • 117 Citations

  • 1065 Altmetric

  • Metrics details

Subjects

  • Biotechnology
  • Nanoscience and technology

Abstract

Cancer progresses by evading the immune system. Elucidating diverse immune evasion strategies is a critical step in the search for next-generation immunotherapies for cancer. Here we report that cancer cells can hijack the mitochondria from immune cells via physical nanotubes. Mitochondria are essential for metabolism and activation of immune cells. By using field-emission scanning electron microscopy, fluorophore-tagged mitochondrial transfer tracing and metabolic quantification, we demonstrate that the nanotube-mediated transfer of mitochondria from immune cells to cancer cells metabolically empowers the cancer cells and depletes the immune cells. Inhibiting the nanotube assembly machinery significantly reduced mitochondrial transfer and prevented the depletion of immune cells. Combining a farnesyltransferase and geranylgeranyltransferase 1 inhibitor, namely, L-778123, which partially inhibited nanotube formation and mitochondrial transfer, with a programmed cell death protein 1 immune checkpoint inhibitor improved the antitumour outcomes in an aggressive immunocompetent breast cancer model. Nanotube-mediated mitochondrial hijacking can emerge as a novel target for developing next-generation immunotherapy agents for cancer.

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Change institution

Buy or subscribe

Access Nature and 54 other Nature Portfolio journals

Get Nature+, our best-value online-access subscription

$29.99 /30days

cancel any time

Learn more

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Learn more

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells (1)
Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells (2)
Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells (3)
Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells (4)
Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells (5)

Similar content being viewed by others

Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells (7)

Mitochondrial DNA-triggered innate immune response: mechanisms and diseases

Article Open access 07 November 2023

Ming-Ming Hu & Hong-Bing Shu

Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells (8)

Macrophage mitochondrial fission improves cancer cell phagocytosis induced by therapeutic antibodies and is impaired by glutamine competition

Article 28 April 2022

Jiang Li, Yingying Ye, … Shicheng Su

Data availability

The data that support the findings of this study are available from the corresponding authors upon reasonable request.

References

  1. Wei, S. C. et al. Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade. Cell 170, 1120–1133.e17 (2017).

    Article CAS Google Scholar

  2. Sharma, P. & Allison, J. P. Dissecting the mechanisms of immune checkpoint therapy. Nat. Rev. Immunol. 20, 75–76 (2020).

    Article CAS Google Scholar

  3. Wolchok, J. Putting the immunologic brakes on cancer. Cell 175, 1452–1454 (2018).

    Article CAS Google Scholar

  4. Kulkarni, A. et al. A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer. Nat. Biomed. Eng. 2, 589–599 (2018).

    Article CAS Google Scholar

  5. Wei, S. C., Duffy, C. R. & Allison, J. P. Fundamental mechanisms of immune checkpoint blockade therapy. Cancer Discov. 8, 1069–1086 (2018).

    Article Google Scholar

  6. Tseng, D. et al. Anti-CD47 antibody–mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response. Proc. Natl Acad. Sci. USA 110, 11103–11108 (2013).

    Article CAS Google Scholar

  7. Sharma, P. & Allison, J. P. The future of immune checkpoint therapy. Science 348, 56–61 (2015).

    Article CAS Google Scholar

  8. Önfelt, B., Nedvetzki, S., Yanagi, K. & Davis, D. M. Cutting edge: membrane nanotubes connect immune cells. J. Immunol. 173, 1511–1513 (2004).

    Article Google Scholar

  9. Sowinski, S. et al. Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission. Nat. Cell Biol. 10, 211–219 (2008).

    Article Google Scholar

  10. Gousset, K. et al. Prions hijack tunnelling nanotubes for intercellular spread. Nat. Cell Biol. 11, 328–336 (2009).

    Article Google Scholar

  11. Osswald, M. et al. Brain tumour cells interconnect to a functional and resistant network. Nature 528, 93–98 (2015).

    Article Google Scholar

  12. Connor, Y. et al. Physical nanoscale conduit-mediated communication between tumour cells and the endothelium modulates endothelial phenotype. Nat. Commun. 6, 8671 (2015).

  13. Rustom, A., Saffrich, R., Markovic, I., Walther, P. & Gerdes, H.-H. Nanotubular highways for intercellular organelle transport. Science 303, 1007–1010 (2004).

    Article CAS Google Scholar

  14. Ahmad, T. et al. Miro1 regulates intercellular mitochondrial transport & enhances mesenchymal stem cell rescue efficacy. EMBO J. 33, 994–1010 (2014).

    CAS Google Scholar

  15. Wang, X. & Gerdes, H. H. Transfer of mitochondria via tunneling nanotubes rescues apoptotic PC12 cells. Cell Death Differ. 22, 1181–1191 (2015).

    Google Scholar

  16. Lu, J. et al. Tunneling nanotubes promote intercellular mitochondria transfer followed by increased invasiveness in bladder cancer cells. Oncotarget 8, 15539–15552 (2017).

    Article Google Scholar

  17. Sena, L. A. et al. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity 38, 225–236 (2013).

    Article CAS Google Scholar

  18. Kumar, A. et al. Enhanced oxidative phosphorylation in NKT cells is essential for their survival and function. Proc. Natl Acad. Sci. USA 116, 7439–7448 (2019).

    Article CAS Google Scholar

  19. Vyas, S., Zaganjor, E. & Haigis, M. C. Mitochondria and cancer. Cell 166, 555–566 (2016).

    Article CAS Google Scholar

  20. Goldman, A. et al. Targeting tumor phenotypic plasticity and metabolic remodeling in adaptive cross-drug tolerance. Sci. Signal. 12, eaas8779 (2019).

    Article Google Scholar

  21. Clutton, G., Mollan, K., Hudgens, M. & Goonetilleke, N. A reproducible, objective method using MitoTracker® fluorescent dyes to assess mitochondrial mass in T cells by flow cytometry. Cytometry 95, 450–456 (2019).

    Article CAS Google Scholar

  22. Pham, A. H., McCaffery, J. M. & Chan, D. C. Mouse lines with photo-activatable mitochondria to study mitochondrial dynamics. Genesis 50, 833–843 (2012).

    Article CAS Google Scholar

  23. Pelletier, M., Billingham, L. K., Ramaswamy, M. & Siegel, R. M. in Methods Enzymol, Vol. 542 (eds Galluzzi, L. & Kroemer, G.) 125–149 (Academic Press, 2014).

  24. Kaplon, J. et al. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature 498, 109–112 (2013).

    Article Google Scholar

  25. Hase, K. et al. M-Sec promotes membrane nanotube formation by interacting with Ral and the exocyst complex. Nat. Cell Biol. 11, 1427–1432 (2009).

    See Also
    The Farnesyltransferase Inhibitor (FTI) L-778,123 Displays Promising Anti-Leukemia Activity

    Article Google Scholar

  26. Hashimoto, M. et al. Potential role of the formation of tunneling nanotubes in HIV-1 spread in macrophages. J. Immunol. 196, 1832–1841 (2016).

    Article CAS Google Scholar

  27. Moskalenko, S. et al. The exocyst is a Ral effector complex. Nat. Cell Biol. 4, 66–72 (2002).

    Article CAS Google Scholar

  28. Hanna, S. J. et al. The role of Rho-GTPases and actin polymerization during macrophage tunneling nanotube biogenesis. Sci. Rep. 7, 8547 (2017).

    Article Google Scholar

  29. Guo, W., Tamanoi, F. & Novick, P. Spatial regulation of the exocyst complex by Rho1 GTPase. Nat. Cell Biol. 3, 353–360 (2001).

    Article CAS Google Scholar

  30. Fransson, Å., Ruusala, A. & Aspenström, P. The atypical Rho GTPases Miro-1 and Miro-2 have essential roles in mitochondrial trafficking. Biochem. Biophys. Res. Commun. 344, 500–510 (2006).

    Article CAS Google Scholar

  31. Glater, E. E., Megeath, L. J., Stowers, R. S. & Schwarz, T. L. Axonal transport of mitochondria requires milton to recruit kinesin heavy chain and is light chain independent. J. Cell Biol. 173, 545–557 (2006).

    Article CAS Google Scholar

  32. Arkwright, P. D. et al. Fas stimulation of T lymphocytes promotes rapid intercellular exchange of death signals via membrane nanotubes. Cell Res. 20, 72–88.

  33. Bustelo, X. R., Sauzeau, V. & Berenjeno, I. M. GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo. Bioessays 29, 356–370 (2007).

    Article CAS Google Scholar

  34. Majumder, B. et al. Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity. Nat. Commun. 6, 6169 (2015).

    Article CAS Google Scholar

Download references

Acknowledgements

This work is supported by grants from the National Institute of Health (NIH AR073135_HLJ, CA236702_SS_HLJ, CA214411_SS and CA229772_SS_Co-I), American Lung Association Discovery Grant (LCD-618834_SS) and Department of Defense (DoD PC180355_HLJ and CA201065_HLJ). This work was performed in part at the Center for Nanoscale Systems (CNS), Harvard University, a member of the National Nanotechnology Coordinated Infrastructure Network (NNCI), supported by the National Science Foundation. We thank M. Haigis and A. Goldman for help with the PhAM mouse studies. K.K. is a Gilead Sciences Fellow of the Life Sciences Research Foundation.

Author information

Authors and Affiliations

  1. Center for Engineered Therapeutics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

    Tanmoy Saha,Chinmayee Dash,Ruparoshni Jayabalan,Sachin Khiste,Arpita Kulkarni,Jayanta Mondal,Hae Lin Jang&Shiladitya Sengupta

  2. Harvard–MIT Program in Health Sciences and Technology, Cambridge, MA, USA

    Tanmoy Saha,Chinmayee Dash,Ruparoshni Jayabalan,Sachin Khiste,Jayanta Mondal&Shiladitya Sengupta

  3. Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA

    Kiran Kurmi

  4. Mitra Biotech, Woburn, MA, USA

    Pradip K. Majumder

  5. Mass General Cancer Center, Harvard Medical School, Boston, MA, USA

    Aditya Bardia

  6. Dana-Farber Cancer Institute, Boston, MA, USA

    Shiladitya Sengupta

Authors

  1. Tanmoy Saha

    View author publications

    You can also search for this author in PubMedGoogle Scholar

  2. Chinmayee Dash

    View author publications

    You can also search for this author in PubMedGoogle Scholar

  3. Ruparoshni Jayabalan

    View author publications

    You can also search for this author in PubMedGoogle Scholar

  4. Sachin Khiste

    View author publications

    You can also search for this author in PubMedGoogle Scholar

  5. Arpita Kulkarni

    View author publications

    You can also search for this author in PubMedGoogle Scholar

  6. Kiran Kurmi

    View author publications

    You can also search for this author in PubMedGoogle Scholar

  7. Jayanta Mondal

    View author publications

    You can also search for this author in PubMedGoogle Scholar

  8. Pradip K. Majumder

    View author publications

    You can also search for this author in PubMedGoogle Scholar

  9. Aditya Bardia

    View author publications

    You can also search for this author in PubMedGoogle Scholar

  10. Hae Lin Jang

    View author publications

    You can also search for this author in PubMedGoogle Scholar

  11. Shiladitya Sengupta

    View author publications

    You can also search for this author in PubMedGoogle Scholar

Contributions

T.S. conceived the project, designed and executed the experiments, analysed the data, prepared the figures, and contributed to writing the manuscript. C.D. and R.J. helped in designing and executing the in vitro experiments. S.K. and J.M. helped in designing and executing the in vivo studies and analysed results. A.K. performed the genotyping experiment, analysed results and helped write the manuscript. K.K. helped with the Dendra2 mice and Seahorse studies. P.K.M. and A.B. helped with human tumour explant studies and contributed to the manuscript writing. H.L.J. and S.S. conceptualized and supervised the project, and guided the experimental design, data analysis and manuscript writing.

Corresponding authors

Correspondence to Hae Lin Jang or Shiladitya Sengupta.

Ethics declarations

Competing interests

S.S. is a co-founder and owns equity in Vyome Therapeutics, Akamara Therapeutics and Invictus Oncology, and receives fees from Famygen and Advamedica. H.L.J. is a founder and owns equity in Curer. A.B. is involved in the following consulting/advisory boards: Pfizer, Novartis, Genentech, Merck, Radius Health, Immunomedics, Taiho, Sanofi, Daiichi Pharma/AstraZeneca, Puma, Biothernostics, Phillips, Eli Lilly and Foundation Medicine; A.B. is also contracted via research/grant to the following institutions: Genentech, Novartis, Pfizer, Merck, Sanofi, Radius Health, Immunomedics, Daiichi Pharma/AstraZeneca and Natera. T.S., C.D., R.J., S.K., A.K., K.K., J.M. and P.K.M. declare no competing interests.

Additional information

Peer review information Nature Nanotechnology thanks the anonymous reviewers for their contribution to the peer review of this work.

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Information

Supplementary Figs. 1–29 and Table 1.

Rights and permissions

About this article

Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells (9)

Cite this article

Saha, T., Dash, C., Jayabalan, R. et al. Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells. Nat. Nanotechnol. 17, 98–106 (2022). https://doi.org/10.1038/s41565-021-01000-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41565-021-01000-4

This article is cited by

Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cells (2024)
Top Articles
Candied pecans recipe - A Dish of Daily Life
Herb Sourdough Stuffing Recipe
Merlex Auto Group in Arlington, VA | 123 Cars Available | Autotrader
nail places open on sunday near me - Kisskh
Latest Posts
Best Sourdough Pizza Crust Recipe On the Planet - Better Baker Club
Welsh Cakes Recipe - easy to follow recipe | The Worktop
Article information

Author: Domingo Moore

Last Updated:

Views: 6216

Rating: 4.2 / 5 (53 voted)

Reviews: 84% of readers found this page helpful

Author information

Name: Domingo Moore

Birthday: 1997-05-20

Address: 6485 Kohler Route, Antonioton, VT 77375-0299

Phone: +3213869077934

Job: Sales Analyst

Hobby: Kayaking, Roller skating, Cabaret, Rugby, Homebrewing, Creative writing, amateur radio

Introduction: My name is Domingo Moore, I am a attractive, gorgeous, funny, jolly, spotless, nice, fantastic person who loves writing and wants to share my knowledge and understanding with you.